Capital One Financial’s iShares Biotechnology ETF IBB Stock Holding History

Capital One Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,455	Closed	-$375K	–	132
2021 Q4	$375K	Sell	2,455 -25	-1%	-$3.87K	0.05%	141
2021 Q3	$401K	Hold	2,480	–	–	0.05%	136
2021 Q2	$406K	Hold	2,480	–	–	0.05%	138
2021 Q1	$373K	Sell	2,480 -877	-26%	-$139K	0.05%	138
2020 Q4	$509K	Sell	3,357 -3,150	-48%	-$450K	0.07%	118
2020 Q3	$881K	Sell	6,507 -110	-2%	-$14.9K	0.11%	108
2020 Q2	$904K	Sell	6,617 -100	-1%	-$12.7K	0.12%	124
2020 Q1	$724K	Buy	+6,717	New	+$773K	0.12%	147

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital One Financial's IBB Position: Q1 2022 in Review

Capital One Financial sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 2,455 shares — an estimated $375K sold.

Capital One Financial first reported a position in IBB in Q1 2020 and held it in 8 quarters. The position peaked at $904K in Q2 2020. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Capital One Financial reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Capital One Financial sold 2,455 iShares Biotechnology ETF shares in Q1 2022, an estimated $375K.
Capital One Financial first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 8 quarters.
Capital One Financial's iShares Biotechnology ETF position peaked at $904K in Q2 2020.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Capital One Financial's 13F filing for Q1 2022, filed 13 Apr 2022.